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Dystrophic muscles 
get overexcited
 
oss of adhesion is a primary suspect for 
the underlying cause of muscular dystro-
phy (MD). Muscles from individuals with MD 
look like they are pulling themselves apart, and 
L
Without the SNF-6 acetyl-
choline transporter (bottom) 
mutant muscles fall apart.
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they are mutant for various members of the dystrophin-
glycoprotein complex (DGC), which links intracellular 
actin to extracellular laminin. But now, Hongkyun Kim, 
Steven McIntire (University of California, San Francisco, 
CA), and colleagues suggest that loss of the DGC results 
in loss of an associated neurotransmitter transporter, thus 
leading to overexcitation of MD muscles.
Kim was screening for alcohol-resistant worms when he chanced upon the trans-
porter mutants. Like worms mutant for the dystrophin homologue 
 
dys-1
 
, the 
 
snf-6
 
 
mutants bent their heads excessively when they tried to move fast. Wild-type SNF-6 
protein promoted uptake of the neurotransmitter acetylcholine into transfected cells, 
and is needed in muscle cells, presumably to mediate similar uptake.
The 
 
snf-6
 
 mutants showed higher neuronal responses downstream of repeated (but not 
individual) electrical stimuli. Loss of dystrophin or its partner syntrophin resulted in delo-
calized SNF-6 in older worms, and SNF-6 coimmunoprecipitated with worm syntrophin.
Adhesion may still be important in MD pathology, as the group does not yet know 
whether all DGC components are in the correct place and functioning properly in the 
 
snf-6
 
 mutant. Teasing apart the transporter and adhesion functions may be easier in 
mammalian systems, although the worm system is still a promising approach for 
exploring downstream effectors of MD disease.
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Slow but steady wins the drug race
 
acteria that survive antibiotic assaults fall into two groups: resistant mutants; 
and the more mysterious persistent cells. Persisters, a known entity since 
1944, survive the intial burst of antibiotics but unlike mutants may succumb to 
later treatments. Nathalie Balaban (now at Hebrew University, Jerusalem, Israel), 
Stanislas Leibler (Rockefeller University, New York, NY), and colleagues now 
find that persisters are a constant presence in the population—a slow-growing 
minority that acts as a reserve population in case of chemical attack.
The alternative explanations for persisters are legion. They might be completely 
dormant, or normal cells caught in a protected part of the cell cycle when the 
antibiotic arrives, or a state induced in response to antibiotic treatment. Balaban 
and colleagues looked at the behavior of single cells immobilized in a microfluidic 
device and saw that the few cells surviving antibiotic treatment were growing 
B
 
slowly even before the drug was added.
Extrapolating from the behavior of 
two mutants that produce an excess of 
persisters, the team deduced that wild-
type cells make persisters both in response 
to time spent in stationary phase and at 
a constant rate during normal growth. 
A slow-growing variant cell (arrow) 
can escape ampicillin (present at 6:50).
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Persisters escape their sluggish state at a slow but appreciable rate.
For basic researchers, the persistence pathway offers a bacterial example of an 
alternative phenotypic state, and one that is somehow generated at a low, constant 
frequency. For clinicians,the pathway may present a target for drugs that would get 
rid of the few bacteria left after conventional antibiotic treatments. 
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Clathrin starts off alone
 
detailed visualization of clathrin 
dynamics by Marcelo Ehrlich, 
Tomas Kirchhausen (Harvard Medical 
School, Boston, MA), and colleagues 
reveals that two events—the initiation 
of clathrin-mediated endocytosis and 
recognition of cargo—are distinct. It 
appears that clathrin-coated pits start 
to form randomly but collapse unless 
stabilized, perhaps by cargo capture.
The Boston team marked clathrin and 
the AP-2 adaptor using fusions that 
allowed dynamic behavior, and collected 
complete datasets that were quantified 
automatically. The intensity of clathrin 
spots grew over time, with most reach-
ing a critical point at 
 
 
 
20 s. By then the 
curvature of the clathrin triskelions may 
become unsupportable without bolster-
ing by other proteins. If labeled cargo 
joined the spots by then or soon after 
then, the spot continued to grow; but 
otherwise the spot dissipated without 
the burst of dynamin accumulation 
characteristic of endocytosing vesicles.
Apart from a few large, inactive 
regions, placement of pits was random 
and did not favor sites of previous pit 
formation. This suggests that static 
pit-forming factories do not exist. An 
as-yet-unidentified pit-initiating protein is, 
however, a distinct possibility.
Kirchhausen says the random formation 
is reminiscent of the random probing 
by dynamic microtubules, which are 
stabilized only if they happen to encoun-
ter their target proteins. The source of 
stabilization for clathrin coats remains 
uncertain. Cargo binding may induce a 
conformational change in an adaptor, 
thus strengthening links from adaptors 
to clathrin or other proteins. 
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A preexisting clathrin coat (green) and cargo 
(red) encounter each other.
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